Skip to content

Clinical trials

Completed Neurodegenerative Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Status: Completed Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20101
20121
20131
20162
20182
20191
20202
20224
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GenSight Biologics4
MODAG GmbH3
Novartis2
TauRx Therapeutics Ltd2
Alterity Therapeutics1
Inmune Bio, Inc.1
Ken Marek, MD1
Medivation, Inc.1
Novartis Pharmaceuticals1
Ono Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases18
Alzheimer Disease9
Nervous System Diseases6
Genetic Diseases, Inborn5
Dementia4
Eye Diseases4
Eye Diseases, Hereditary4
Mitochondrial Diseases4
Multiple System Atrophy4
Optic Atrophy, Hereditary, Leber4

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.